| 2025-02-14 |
16th World Bispecific Summit 2025 |
| 2024-12-03 |
Week 1, December 2024: Biparatopic Antibodies |
| 2024-11-26 |
Week 4, November 2024: The PD-1, PD-L1, and VEGF Train |
| 2024-10-08 |
Mechanisms of Action of Bispecific Antibodies in Cancer Therapy |
| 2024-10-04 |
September 2024: Bispecific Antibodies in Oncology |
| 2024-09-20 |
What is High-Throughput Expression and Production? |
| 2024-09-13 |
What are Innovative Antibody Formats? |
| 2024-09-11 |
What are Bispecific Antibodies? |
| 2024-09-09 |
15th World Bispecifics Summit 2024 – Boston: Highlights and Event Recap |
| 2024-08-09 |
Transforming In Vivo Research with Bispecific Antibodies |
| 2024-07-09 |
Week 2, July 2024: An Update on Alzheimer’s Antibody Drugs |
| 2024-06-21 |
The 15th Annual World Bispecific Summit |
| 2024-05-18 |
PEGS 2024 – Boston: Highlights and Event Recap |
| 2024-05-14 |
The Emergence and Evolution of scFvs |
| 2024-05-08 |
Engineered Antibody Formats: A Historical Perspective |
| 2024-05-02 |
Innovating Cancer Treatment: Bispecific Antibody Drug Conjugates |
| 2024-04-16 |
Week 3, Apr 2024: Bispecific ADCs |
| 2024-04-01 |
10 Intriguing Facts About Antibody Production |
| 2024-03-29 |
Bispecific Antibodies: Design, Development, and Therapeutic Potential |
| 2024-03-25 |
Antibody Engineering: Enhancing Efficacy and Reducing Immunogenicity |
| 2024-03-12 |
Week 2, Mar 2024: The Battle Against Cancer |
| 2024-02-14 |
Antibody Basics: Part 3 - Antibody formats: Bispecific Antibodies (bsAbs) |
| 2024-02-14 |
Week 2, Feb 2024: Combination Therapies |
| 2024-01-27 |
Bispecific Antibody Production |
| 2024-01-20 |
Antibody Engineering: From Bispecifics to Humanization |
| 2023-12-18 |
Next-Generation Antibody Formats |
